Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.46 |
| ▸ | CA1 | P00915 | 6/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | ELANE | P08246 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (Chloromethyl)Benzene SCHEMBL28421276 | 0.90 | ALDH1A1 (0.44) | CA2CA1CA9ELANEFAAH | |
| (Chloromethyl)Benzene SCHEMBL29794364 | 0.86 | — | — | |
| (Chloromethyl)Benzene SCHEMBL29919724 | 0.86 | — | — | |
| (Chloromethyl)Benzene SCHEMBL4746769 | 0.86 | CALM1 (0.53) | ELANEALDH1A1HSD17B10TDP1CALM1 | |
| (Chloromethyl)Benzene SCHEMBL1616642 | 0.86 | — | — | |
| (Chloromethyl)Benzene SCHEMBL6422666 | 0.86 | CALM1 (0.53) | ELANEALDH1A1HSD17B10TDP1CALM1 | |
| (Chloromethyl)Benzene SCHEMBL1331085 | 0.86 | — | — | |
| (Chloromethyl)Benzene SCHEMBL7413 | 0.86 | — | — | |
| SCHEMBL21317609 | 0.86 | CALM1 (0.53) | ELANEALDH1A1HSD17B10TDP1CALM1 | |
| (Chloromethyl)Benzene SCHEMBL28213819 | 0.83 | CALM1 (0.45) | CA2CA1ELANEALDH1A1CALM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103305621-B | Fluorescent method of 5-hydroxymethylcytosine based on FRET (Forster Resonance Energy Transfer) principle | UNIV WUHAN | 2015-05-13 | — | — | CN | disclosed |
| CN-103360286-A | Simple preparation method for sulfonyl chloride | UNIV BEIJING CHEMICAL | 2013-10-23 | — | — | CN | disclosed |
| CN-103351315-A | General preparation method of sulfonyl chloride | UNIV BEIJING CHEMICAL | 2013-10-16 | — | — | CN | disclosed |
| CN-103305621-A | Fluorescent method of 5-hydroxymethylcytosine based on FRET (Forster Resonance Energy Transfer) principle | UNIV WUHAN | 2013-09-18 | — | — | CN | disclosed |
| CN-103193687-A | Method for preparing sulfonyl chloride in environment-friendly mode | UNIV BEIJING CHEMICAL | 2013-07-10 | — | — | CN | disclosed |
| US-20090286837-A1 | Oxadiazole compounds as urokinase inhibitors | WILEX AG (DE) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286837-A1 | Oxadiazole compounds as urokinase inhibitors | PLAUR, PLAU, PLAT | CA2 2434/4885CA1 1265/4885CA9 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.